SPL7013 ophthalmic drops potential, page-8

Starpharma headquarters
15th January 2019 10:00am
General boardroom meeting


JF: Next item on the agenda is our progress with eye drops for viral conjunctivitis using SPL7013. I have asked George to give us a latest update. George?

G?: Yes, good morning everyone.
As you know our hard work has resulted in last months announcement that “our eye drops are seen to be working “ - ha ha.
Well, unfortunately it wasn't enough to attract new partners willing to cough up some cash. So we would have to go it alone to commercialise it.

JF: Oh dear. Well, if we did, when would it be ready, and how much would it cost?

G?: We could have product in the shops by April 2020, at a total cost of about 8mill!

JF: OH! Oh... ooookay...well, thank you George.

Door shuts
Gentle laughter and shaking of heads by all board members

JF: Now, next on the agenda is....